Skip to main content

Year: 2025

CORRECTION – Eagle Bancorp, Inc. Announces Third Quarter 2025 Results and Cash Dividend

BETHESDA, Md., Oct. 23, 2025 (GLOBE NEWSWIRE) — In a release issued under the same headline on Wednesday, October 22nd by Eagle Bancorp, Inc. (Nasdaq: EGBN), please note that the links to the conference call were outdated. The corrected release follows: Eagle Bancorp, Inc. (“Eagle” or the “Company”) (NASDAQ: EGBN), the Bethesda-based holding company for EagleBank, one of the largest community banks in the Washington D.C. area, reported its unaudited results for the third quarter ended September 30, 2025. Eagle reported a net loss of $67.5 million or $2.22 per share for the third quarter 2025, compared to a net loss of $69.8 million or $2.30 per share for the second quarter. The $2.3 million improvement in the net loss from the prior quarter is primarily due to a $24.9 million decrease in provision expense,...

Continue reading

Kearny Financial Corp. Announces First Quarter Fiscal 2026 Results and Declaration of Cash Dividend

FAIRFIELD, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) — Kearny Financial Corp. (NASDAQ GS: KRNY) (the “Company”), the holding company of Kearny Bank (the “Bank”), reported net income for the quarter ended September 30, 2025 of $9.5 million, or $0.15 per diluted share, compared to $6.8 million, or $0.11 per diluted share, for the quarter ended June 30, 2025. The Company also announced that its Board of Directors has declared a quarterly cash dividend of $0.11 per share, payable on November 19, 2025, to stockholders of record as of November 5, 2025. Craig L. Montanaro, President and Chief Executive Officer, commented, “We are pleased to report a strong quarter that underscores our continued momentum in profitability growth. Net interest margin expansion of 10 basis points, in conjunction with solid credit quality and well-controlled expenses,...

Continue reading

Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women

Consistency of BMD gains presented at NAMS 2025 demonstrate EB613’s efficacy in both young postmenopausal women and in women 10 years post-menopause Data further support EB613 potential as a first-in-class oral anabolic treatment option that could dramatically expand patient access to bone-building therapy Entera Plans to Initiate Global Registrational Phase 3 Study Following July 2025 FDA Concurrence JERUSALEM, Oct. 23, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (Nasdaq: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported new clinical data from a post-hoc analysis of its Phase 2 trial of EB613, at the 2025 North American Menopause Society (NAMS) Annual Meeting in a poster presentation titled “EB613 (Oral PTH[1-34] Tablets) Increases BMD Over 6 Months in Early Postmenopausal Women...

Continue reading

Totaligent’s Omni-Channel Digital Communications Platform Is an All-in-One Marketing Game Changer

Designed to Integrate Programmatic Advertising, Social Media, Email ESP, SMS, and Push Notifications BOCA RATON, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) — Totaligent, Inc. (“Totaligent” or “the Company”)(OTCID: TGNT), a leader in intelligent business marketing and data solutions, today announces that the Company is preparing for the commercial launch of its all-in-one enterprise marketing platform, which is currently in closed beta and designed to replace fragmented tech stacks with a unified, AI-powered solution. The new platform consolidates core marketing channels, including Programmatic Advertising, Social-media, Email ESP, SMS, and Push Notifications, into a single, powerful interface. With built-in Smart Capture, advanced audience creation, and real-time analytics, the platform eliminates the need for external API setups or...

Continue reading

Itron and Gordian Technologies Collaborate to Bring AI-Powered Intelligence to the Grid Edge

AI at the Grid Edge Enables Utilities to Strengthen Grid ReliabilityAI at the Grid Edge Enables Utilities to Strengthen Grid Reliability LIBERTY LAKE, Wash., Oct. 23, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, is working with Gordian Technologies (Gordian) to bring artificial intelligence (AI) and machine learning (ML) to the grid edge. Itron is enhancing its Grid Edge Intelligence (GEI) portfolio with Gordian’s AI and ML technology and enabling its developer community to access that technology through Itron’s Distributed Intelligence (DI) Developer Program. This enhancement to Itron’s GEI portfolio further enables utilities to improve grid resilience, disaster management and prevention, operational efficiency and to deliver affordable energy...

Continue reading

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Significant milestones are approaching in drug development; additional digital asset purchases expected Preparation for FDA IND application expected to commence before year-end SARASOTA, FL, Oct. 23, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced a comprehensive update detailing progress for lead candidate SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder (PTSD) and stress-induced anxiety, and key achievements under Silo’s new digital assets treasury platform launched in August 2025. Biopharmaceutical Platform: Silo is advancing SPC-15, its lead therapeutic candidate, through the final preparations requiredprior to submitting an investigational new drug application...

Continue reading

Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AG

Biofrontera Inc. acquires full U.S. rights to Ameluz® and RhodoLED®, including New Drug Application and associated patents, from former parent Biofrontera AG. New earnout structure reduces payment rate to 12%–15% of U.S. net sales from 25%–35%. Closing releases final $2.5 million of $11 million financing led by existing investors Rosalind Advisors and AIGH Capital Management, which is expected to fund Biofrontera Inc. to profitability.WOBURN, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the closing of its restructuring and asset purchase agreement with its former parent company, Biofrontera AG. Under the transaction, Biofrontera Inc. has...

Continue reading

24/7 Market News: VENU Hitting All the Right Notes and Scaling to Meet Record Demand

Momentum Amplified, as VENU Executes at Scale DENVER, Oct. 23, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that VENU (NYSE American: VENU), a growing operator of premium hospitality and live entertainment venues across the U.S., has achieved a series of transformative milestones that position the company for accelerated national growth and long-term profitability. VENU’s recent performance underscores its ability to merge real estate, entertainment, and community impact into one unified, scalable business model. Over the past 60 days, VENU achieved $23 million in Luxe FireSuite sales, driving a 250% year-over-year increase and signaling unprecedented record investor demand. The company’s $5 billion development...

Continue reading

American Airlines Names Nathaniel Pieper Chief Commercial Officer

Nathaniel PieperAmerican Airlines names Nathaniel Pieper Chief Commercial OfficerFORT WORTH, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) — American Airlines Group Inc. (NASDAQ: AAL) today announced that Nathaniel (Nat) Pieper has been named Chief Commercial Officer. Pieper, currently CEO of the oneworld alliance, will assume his new role effective Nov. 3. He will report to American’s CEO Robert Isom. “Nat is a world-class, results-oriented leader who has achieved tremendous success throughout his entire career,” said Isom. “He is well-versed in the airline business, having led teams across multiple disciplines at Northwest, Delta and Alaska. Nat’s experience and expertise, coupled with his recent work with us leading oneworld, make him incredibly well-suited to lead our Commercial team moving forward.” As Chief Commercial Officer,...

Continue reading

Vivakor Closes $40 Million Commodity Intermediation Facility

Facility to provide additional credit for expansion of crude oil supply and trading Dallas, TX, Oct. 23, 2025 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse, and remediation services, today announced the closing of its previously announced $40 million commodity intermediation credit facility with a single wholesaler. The facility is intended to provide additional credit support for the growth and expansion of Vivakor’s crude oil trading platform. The Facility, known as a commodity intermediation facility (the “Facility”), functions as a working capital and credit support arrangement for physical crude oil transactions conducted by Vivakor Supply & Trading, LLC (“VST”). Under the terms of the Facility, the wholesaler will provide...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.